Back to Search
JILLIAN O'SHAUGHNESSY, MD
MD
Student in an Organized Health Care Education/Training Program
NPI: 1437903622Individual
Specialties, Licenses & Credentials
Student in an Organized Health Care Education/Training ProgramPrimary
Student in an Organized Health Care Education/Training Program
Code: 390200000X
Research & Publications (20)
RiBBON 1 and RiBBON 2: phase III trials of bevacizumab with standard chemotherapy for metastatic breast cancer.
PMID 18757267·Clin Breast Cancer·2008
8-other
Management of febrile neutropenia and cardiac toxicity in the adjuvant treatment of breast cancer.
PMID 18282366·Clin Breast Cancer·2007
6-review
Capecitabine/Taxane combination therapy: evolving clinical utility in breast cancer.
PMID 16764743·Clin Breast Cancer·2006
6-review
Phase II trial of weekly docetaxel/ gemcitabine as first-line chemotherapy in patients with locally recurrent or metastatic breast cancer.
PMID 16595033·Clin Breast Cancer·2006
3-trial
Feasibility of quantifying the effects of epoetin alfa therapy on cognitive function in women with breast cancer undergoing adjuvant or neoadjuvant chemotherapy.
PMID 15748464·Clin Breast Cancer·2005
3-trial
New perspectives with antimetabolites in the management of breast cancer.
PMID 14754465·Clin Breast Cancer·2004
8-other
Pegylated liposomal doxorubicin in the treatment of breast cancer.
PMID 14715106·Clin Breast Cancer·2003
6-review
Chemotherapy-related cognitive dysfunction in breast cancer.
PMID 14702917·Semin Oncol Nurs·2003
6-review
Chemotherapy-induced cognitive dysfunction: a clearer picture.
PMID 14705598·Clin Breast Cancer·2003
6-review
Phase II trial of gemcitabine plus trastuzumab in metastatic breast cancer patients previously treated with chemotherapy: preliminary results.
PMID 12057040·Clin Breast Cancer·2002
3-trial
Superior survival with capecitabine plus docetaxel combination therapy in anthracycline-pretreated patients with advanced breast cancer: phase III trial results.
PMID 12065558·J Clin Oncol·2002
3-trial
Treatment and prevention of intraepithelial neoplasia: an important target for accelerated new agent development.
PMID 11839647·Clin Cancer Res·2002
8-other
Clinical experience of capecitabine in metastatic breast cancer.
PMID 11841930·Eur J Cancer·2002
8-other
Results of a phase II open-label, nonrandomized trial of oral satraplatin in patients with metastatic breast cancer.
PMID 19459042·Breast Cancer Res Treat·2009
3-trial
Data courtesy of the U.S. National Library of Medicine (NLM). Ltrl is not affiliated with or endorsed by NLM.
Contact & Hours
- Address
- 1 BAYLOR PLZ
HOUSTON, TX 77030 - Phone
- (585) 739-8589
Quick Facts
- NPI
- 1437903622
- Entity Type
- Individual
- Gender
- Female
- Medicare
- Not confirmed
- Specialties
- 1
- Locations
- 1
- Publications
- 20
Are you this provider?
Claim Your Profile